The drug manufacturer said its investors would receive 62.5 pence per share under the deal, a 40.9 per cent premium to its closing share price on Thursday.Read More
You might also be interested in reading Bitcoin price prediction: $60K retest possible amid U.S. tariffs, Iran tensions.